Meningococcal quadrivalent (serogroups A, C, W135, and Y) conjugate vaccine (Menveo(®)): profile report

Affiliations

Review

Emma D Deeks. Paediatr Drugs. 2012.

. 2012 Feb 1;14(1):63-5.

doi: 10.2165/11206930-000000000-00000.

No abstract available

Similar articles

Meningococcal group A, C, Y and W-135 conjugate vaccine.
Harrison LH, Mohan N, Kirkpatrick P. Harrison LH, et al. Nat Rev Drug Discov. 2010 Jun;9(6):429-30. doi: 10.1038/nrd3194. Nat Rev Drug Discov. 2010. PMID: 20514064
Quadrivalent meningococcal conjugate vaccines.
Pace D, Pollard AJ, Messonier NE. Pace D, et al. Vaccine. 2009 Jun 24;27 Suppl 2:B30-41. doi: 10.1016/j.vaccine.2009.05.003. Epub 2009 May 27. Vaccine. 2009. PMID: 19477560 Review.
Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients.
Wyplosz B, Derradji O, Hong E, François H, Durrbach A, Duclos-Vallée JC, Samuel D, Escaut L, Launay O, Vittecoq D, Taha MK. Wyplosz B, et al. Transpl Infect Dis. 2015 Apr;17(2):322-7. doi: 10.1111/tid.12359. Epub 2015 Mar 6. Transpl Infect Dis. 2015. PMID: 25645691 Clinical Trial.
Immunisation update: Meningococcal B and ACWY vaccines.
Davidson GT, Heaton PA, Paul SP. Davidson GT, et al. J Fam Health. 2015 Nov-Dec;25(6):22-5. J Fam Health. 2015. PMID: 26749934 No abstract available.
Immunogenicity and safety of a meningococcal serogroup A, C, Y and W glycoconjugate vaccine, ACWY-TT.
Findlow H, Borrow R. Findlow H, et al. Adv Ther. 2013 May;30(5):431-58. doi: 10.1007/s12325-013-0032-5. Epub 2013 May 28. Adv Ther. 2013. PMID: 23712402 Review.